1,162
Views
24
CrossRef citations to date
0
Altmetric
Addendum

Bioengineered lysozyme in combination therapies for Pseudomonas aeruginosa lung infections

, , , , &
Pages 143-147 | Received 17 Jan 2014, Accepted 24 Feb 2014, Published online: 26 Feb 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lin Cui, Huoqing Huang, Honglian Zhang, Xiaolu Wang, Xing Qin, Tao Tu, Jie Zhang, Xiaoyun Su, Huimin Yu, Yingguo Bai, Huiying Luo, Bin Yao & Yuan Wang. (2022) Recombinant expression of hen egg white lysozyme with the assistance of xylanase fusion partner in Pichia pastoris. Bioengineered 13:5, pages 13860-13871.
Read now

Articles from other publishers (23)

Parminder Singh, Roberto Hernandez‐Rauda & Oscar Peña‐Rodas. (2023) Preventative and therapeutic potential of animal milk components against COVID‐19: A comprehensive review. Food Science & Nutrition 11:6, pages 2547-2579.
Crossref
Merve Kaplan, Arif Sercan Şahutoğlu, Sümeyye Sarıtaş, Hatice Duman, Ayşenur Arslan, Burcu Pekdemir & Sercan Karav. (2022) Role of milk glycome in prevention, treatment, and recovery of COVID-19. Frontiers in Nutrition 9.
Crossref
María Escobar‐Salom, Gabriel Torrens, Elena Jordana‐Lluch, Antonio Oliver & Carlos Juan. (2022) Mammals' humoral immune proteins and peptides targeting the bacterial envelope: from natural protection to therapeutic applications against multidrug‐resistant Gram ‐negatives . Biological Reviews 97:3, pages 1005-1037.
Crossref
Valentina Gallo, Francesco Giansanti, Alyexandra Arienzo & Giovanni Antonini. (2022) Antiviral properties of whey proteins and their activity against SARS-CoV-2 infection. Journal of Functional Foods 89, pages 104932.
Crossref
Dilem Ruhluel, Siobhan O'Brien, Joanne L Fothergill & Daniel R Neill. (2022) Development of liquid culture media mimicking the conditions of sinuses and lungs in cystic fibrosis and health. F1000Research 11, pages 1007.
Crossref
Dilem Ruhluel, Siobhan O'Brien, Joanne L Fothergill & Daniel R Neill. (2022) Development of liquid culture media mimicking the conditions of sinuses and lungs in cystic fibrosis and health. F1000Research 11, pages 1007.
Crossref
Patrizia Ferraboschi, Samuele Ciceri & Paride Grisenti. (2021) Applications of Lysozyme, an Innate Immune Defense Factor, as an Alternative Antibiotic. Antibiotics 10:12, pages 1534.
Crossref
Dmitriy N. Shurpik, Yulia I. Aleksandrova, Olga A. Mostovaya, Viktoriya A. Nazmutdinova, Pavel V. Zelenikhin, Evgenia V. Subakaeva, Timur A. Mukhametzyanov, Peter J. Cragg & Ivan I. Stoikov. (2021) Water-soluble pillar[5]arene sulfo-derivatives self-assemble into biocompatible nanosystems to stabilize therapeutic proteins. Bioorganic Chemistry 117, pages 105415.
Crossref
Ian Blumenthal, Lydia R. Davis, Chet M. Berman & Karl E. Griswold. (2021) Nonclassical antagonism between human lysozyme and AMPs against Pseudomonas aeruginosa . FEBS Open Bio 11:3, pages 705-713.
Crossref
Jingxin Zhu, Haijuan Wu, Ding Wang, Yanlong Ma & Lan Jia. (2021) A Facile Strategy for Fabrication Lysozyme-Loaded Mesoporous Silica Nanotubes from Electrospun Silk Fibroin Nanofiber Templates. Molecules 26:4, pages 1073.
Crossref
Jaclyn Kelly Mann & Thumbi Ndung'u. (2020) The potential of lactoferrin, ovotransferrin and lysozyme as antiviral and immune-modulating agents in COVID-19. Future Virology 15:9, pages 609-624.
Crossref
Gabriel Torrens, Maria Escobar-Salom, Antonio Oliver & Carlos Juan. (2020) Activity of mammalian peptidoglycan-targeting immunity against Pseudomonas aeruginosa. Journal of Medical Microbiology 69:4, pages 492-504.
Crossref
Yanan Wang, Shangyong Li, Mengfei Jin, Qi Han, Songshen Liu, Xuehong Chen & Yantao Han. (2020) Enhancing the Thermo-Stability and Anti-Bacterium Activity of Lysozyme by Immobilization on Chitosan Nanoparticles. International Journal of Molecular Sciences 21:5, pages 1635.
Crossref
Sai Wen, Dongmei Yao, Xiaoyu Liu & Fenghuan Wang. (2019) A Novel Fluorescence Resonance Energy Transfer-Based High-Throughput Screening Method for Generation of Lysozyme with Improved Antimicrobial Activity against Escherichia coli Strains . Journal of Agricultural and Food Chemistry 67:45, pages 12584-12589.
Crossref
Gabriel Torrens, Isabel M. Barceló, Marcelo Pérez-Gallego, Maria Escobar-Salom, Sara Tur-Gracia, Marta Munar-Bestard, María del Mar González-Nicolau, Yoandy José Cabrera-Venegas, Estefany Nayarith Rigo-Rumbos, Gabriel Cabot, Carla López-Causapé, Estrella Rojo-Molinero, Antonio Oliver & Carlos Juan. (2019) Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins. Scientific Reports 9:1.
Crossref
Shubhrima Ghosh, Shahenvaz Alam, Anurag S. Rathore & S. K. Khare. 2019. Therapeutic Enzymes: Function and Clinical Implications. Therapeutic Enzymes: Function and Clinical Implications 131 150 .
Jacob Witten, Tahoura Samad & Katharina Ribbeck. (2018) Selective permeability of mucus barriers. Current Opinion in Biotechnology 52, pages 124-133.
Crossref
Laura Bricio-Moreno, Victoria H. Sheridan, Ian Goodhead, Stuart Armstrong, Janet K.L. Wong, Elaine M. Waters, Joscelyn Sarsby, Stavros Panagiotou, James Dunn, Adrita Chakraborty, Yongliang Fang, Karl E. Griswold, Craig Winstanley, Joanne L. Fothergill, Aras Kadioglu & Daniel R. Neill. (2018) Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa. Nature Communications 9:1.
Crossref
Lise Schoonen, Sjors Maassen, Roeland J. M. Nolte & Jan C. M. van Hest. (2017) Stabilization of a Virus-Like Particle and Its Application as a Nanoreactor at Physiological Conditions. Biomacromolecules 18:11, pages 3492-3497.
Crossref
Gabriel Torrens, Marcelo Pérez-Gallego, Bartolomé Moya, Marta Munar-Bestard, Laura Zamorano, Gabriel Cabot, Jesús Blázquez, Juan A. Ayala, Antonio Oliver & Carlos Juan. (2017) Targeting the permeability barrier and peptidoglycan recycling pathways to disarm Pseudomonas aeruginosa against the innate immune system. PLOS ONE 12:7, pages e0181932.
Crossref
Jacob Witten & Katharina Ribbeck. (2017) The particle in the spider's web: transport through biological hydrogels. Nanoscale 9:24, pages 8080-8095.
Crossref
Sarah M. Dostal, Yongliang Fang, Jonathan C. Guerrette, Thomas C. Scanlon & Karl E. Griswold. (2015) Genetically Enhanced Lysozyme Evades a Pathogen Derived Inhibitory Protein. ACS Chemical Biology 10:4, pages 1110-1117.
Crossref
Daniel C. Osipovitch & Karl E. Griswold. (2014) Fusion with a cell wall binding domain renders autolysin LytM a potent anti-Staphylococcus aureus agent. FEMS Microbiology Letters 362:2, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.